← Leaderboards
Christian C Melander
California Institute Of Technology
$13,384,640
Attributed
$18,174,524
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,174,524 · 10
By mechanism
R01$16,177,863 · 6
T32$1,281,430 · 1
R21$682,815 · 2
F32$32,416 · 1
Top collaborators
- John S Gunn8 shared
- Hui Wu6 shared
- John Cavanagh4 shared
- Dan L. Feldheim4 shared
- Ryan T Gill4 shared
- Danna B Zimmer4 shared
- Daniel Vincent Zurawski4 shared
Most similar at California Institute Of Technology
Same institution · by research overlap
- Frances H Arnold$5,903,349
Others in their field
Top investigators on “Antibiotics”
- Laurence H Baker · University Of Michigan At Ann Arbor$52,071,546
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,812,829
- Taha E Taha · Johns Hopkins University$37,363,329
- Urs Ochsner · Crestone, Inc.$36,950,837
- Deborah T Hung · Massachusetts General Hospital$36,871,538
- Ryan Cirz · Revagenix, Inc.$35,410,554
Research focus
AntibioticsIn VivoBacteriaResistanceSmall MoleculePharmaceutical PreparationsPathogenInfectionFutureStructureDesignMedicalNovel TherapeuticsAnalogMouse ModelBaseCombatLeadAntibiotic ResistanceCommunicable DiseasesStructure-Activity RelationshipIn VitroDoseScaffold
Grant awards (41)
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants$1,447,329
R01 · FY2025 · AI · contact PI
Mechanisms of the Development and Maintenance of Salmonella Gallbladder Carriage$542,867
R01 · FY2025 · AI
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$321,270
T32 · FY2025 · GM · contact PI
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants$734,354
R01 · FY2024 · AI · contact PI
Mechanisms of the Development and Maintenance of Salmonella Gallbladder Carriage$548,318
R01 · FY2024 · AI
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$329,616
T32 · FY2024 · GM · contact PI
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants$739,601
R01 · FY2023 · AI · contact PI
Mechanisms of the Development and Maintenance of Salmonella Gallbladder Carriage$555,408
R01 · FY2023 · AI
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$318,321
T32 · FY2023 · GM · contact PI
Mechanisms of the Development and Maintenance of Salmonella Gallbladder Carriage$11,839
R01 · FY2023 · AI
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants$769,579
R01 · FY2022 · AI · contact PI
Development of Antibiotic Adjuvants for Gram-Negative Bacteria$720,934
R01 · FY2022 · AI · contact PI
Mechanisms of the Development and Maintenance of Salmonella Gallbladder Carriage$650,502
R01 · FY2022 · AI
Small molecule inhibitors of cariogenic biofilms$381,930
R01 · FY2022 · DE
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$312,223
T32 · FY2022 · GM · contact PI
Mechanisms of the Development and Maintenance of Salmonella Gallbladder Carriage$72,460
R01 · FY2022 · AI
Development of Antibiotic Adjuvants for Gram-Negative Bacteria$725,817
R01 · FY2021 · AI · contact PI
Mechanisms of the Development and Maintenance of Salmonella Gallbladder Carriage$672,803
R01 · FY2021 · AI
Small molecule inhibitors of cariogenic biofilms$392,247
R01 · FY2021 · DE
Mechanisms of the Development and Maintenance of Salmonella Gallbladder Carriage$50,944
R01 · FY2021 · AI
Development of Antibiotic Adjuvants for Gram-Negative Bacteria$730,556
R01 · FY2020 · AI · contact PI
Small molecule inhibitors of cariogenic biofilms$498,315
R01 · FY2020 · DE
Development of Antibiotic Adjuvants for Gram-Negative Bacteria$735,159
R01 · FY2019 · AI · contact PI
SMALL MOLECULE INHIBITORS OF CARIOGENIC BIOFILMS$337,207
R01 · FY2019 · DE
SMALL MOLECULE INHIBITORS OF CARIOGENIC BIOFILMS$85,769
R01 · FY2019 · DE
Development of Antibiotic Adjuvants for Gram-Negative Bacteria$794,128
R01 · FY2018 · AI · contact PI
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negative Pathogens$530,758
R01 · FY2018 · AI · contact PI
SMALL MOLECULE INHIBITORS OF CARIOGENIC BIOFILMS$349,461
R01 · FY2018 · DE
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati$507,293
R01 · FY2017 · AI · contact PI
NMR Studies of Bacterial Regulatory Proteins$326,284
R01 · FY2017 · GM
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati$436,530
R01 · FY2016 · AI
NMR Studies of Bacterial Regulatory Proteins$326,284
R01 · FY2016 · GM
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati$412,744
R01 · FY2015 · AI
NMR Studies of Bacterial Regulatory Proteins$328,776
R01 · FY2015 · GM
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati$425,001
R01 · FY2014 · AI
NMR Studies of Bacterial Regulatory Proteins$336,666
R01 · FY2014 · GM
Circumventing Tetracyline Resistance Mechanisms with Doxycyline-Conjugated Gold N$178,713
R21 · FY2012 · AI · contact PI
Circumventing Tetracyline Resistance Mechanisms with Doxycyline-Conjugated Gold N$191,062
R21 · FY2011 · AI · contact PI
Sequence Specific Targeting of poly-CUG Motifs$159,284
R21 · FY2008 · AR · contact PI
Sequence Specific Targeting of poly-CUG Motifs$153,756
R21 · FY2007 · AR · contact PI
SEQUENCE SPECIFIC ALKYLATION OF DNA$32,416
F32 · FY2000 · GM